Enzolytics Inc (ENZC)

[falon]

Yesterdays News is a necessary service for ENZC to develop and manufacture mAbs.

Enzolytics Inc. to leverage Samsung Biologics' development and manufacturing expertise to advance both Anti-HIV and Anti-SARS-CoV-2 Monoclonal Antibody Therapies to IND.

Samsung Biologics to offer a seamless, end-to-end CDMO service with support from its San Francisco R&D Center.

Much more to come in the weeks and months ahead.

ENZC is a Biotech company and nothing happens quickly with such companies.

ENZC has made tremendous progress since the merger.

The biggest setback was not being able to get the ITV-1 to the market without doing the trials again.

The trials will be redone and they probably won't be finished until next year.

Once ENZC reach certain milestones with the monoclonal antibodes they have been producing they have an expectation of Big Pharma coming on board.

Two of the key milestones is the animal testing and toxicology tests as these will help determine how safe it is to test on humans.

ENZC is just following the PROTOCOLS necessary to move their tech forward.

It is just going to take time.

Many things good and not so good will be happening along the way

Just think about what Charles said about the licensees already lining up to get a piece of the ever growing pie.

Every time ENZC reaches a significant milestone they become more and more valuable.

We are encouraged by the positive feedback received from pharmaceutical companies who have acknowledged an interest in partnering upon achievement of defined milestones.